APA

Wu X., Wynne C., Xu C., Gan Y., Wang C., Thomas B. E., Yu J., Li S. & Zhang L. (20191118). A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Chicago

Wu Xiaoyun, Wynne Chris, Xu Chenchao, Gan Yiting, Wang Chaohe, Thomas Bert E, Yu Jin-Chen, Li Shengfeng and Zhang Li. 20191118. A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Harvard

Wu X., Wynne C., Xu C., Gan Y., Wang C., Thomas B. E., Yu J., Li S. and Zhang L. (20191118). A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

MLA

Wu Xiaoyun, Wynne Chris, Xu Chenchao, Gan Yiting, Wang Chaohe, Thomas Bert E, Yu Jin-Chen, Li Shengfeng and Zhang Li. A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 20191118.